Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Neurodegenerative disorders such as Parkinson and Alzheimer disease cause motor and cognitive dysfunction and belong to a heterogeneous group of common and disabling disorders. Although the complex molecular pathophysiology of neurodegeneration is largely unknown, major advances have been achieved by elucidating the genetic defects underlying mendelian forms of these diseases. This has led to the discovery of common pathophysiological pathways such as enhanced oxidative stress, protein misfolding and aggregation and dysfunction of the ubiquitin-proteasome system. Here, we describe loss-of-function mutations in a previously uncharacterized, predominantly neuronal P-type ATPase gene, ATP13A2, underlying an autosomal recessive form of early-onset parkinsonism with pyramidal degeneration and dementia (PARK9, Kufor-Rakeb syndrome). Whereas the wild-type protein was located in the lysosome of transiently transfected cells, the unstable truncated mutants were retained in the endoplasmic reticulum and degraded by the proteasome. Our findings link a class of proteins with unknown function and substrate specificity to the protein networks implicated in neurodegeneration and parkinsonism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A similar phenotype has also been described in the context of loss‐of‐function mutations in the P‐type ATPase gene ATP13A2, in which recessive, early‐onset PD has been linked to defective acidification of lysosomes and insufficient autophagy (Ramirez et al, 2006).”
From Autophagy in major human diseases (2021) · cites this paper as Ramirez et al, 2006
Citations
Cites
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 1×
“By mutation screening or linkage analysis, we excluded the known autosomal recessive Parkinson disease genes and loci: PARK2 (also known as Parkin ; ref”
BackgroundHereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
The RIN: an RNA integrity number for assigning integrity values to RNA measurements
Schroeder, A., Mueller, O., Stocker, S., Salowsky, R., Leiber, M., Gassmann, M., Lightfoot, S., Menzel, W., Granzow, M., & Ragg, T. (2006) · BMC Molecular Biology · doi:10.1186/1471-2199-7-3 · Cited by 2,623
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300227200 · Cited by 1,429
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
Proteolysis: from the lysosome to ubiquitin and the proteasome
Ciechanover, A. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1552 · Cited by 1,133
Evolution of Substrate Specificities in the P-Type ATPase Superfamily
Axelsen, K. B., & Palmgren, M. G. (1998) · Journal of Molecular Evolution · doi:10.1007/pl00006286 · Cited by 910
Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases
Selkoe, D. J. (2004) · Nature Cell Biology · doi:10.1038/ncb1104-1054 · Cited by 863
Cited by
Items 301–400 of 1,000
van Veen, S., Sørensen, D. M., Holemans, T., Holen, H. W., Palmgren, M. G., & Vangheluwe, P. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00048 · Cited by 88
Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson’s Disease
Monfrini, E., & Fonzo, A. D. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-49969-7_1 · Cited by 98
A Critical Assessment of Exosomes in the Pathogenesis and Stratification of Parkinson’s Disease
Tofaris, G. K. (2017) · Journal of Parkinson’s Disease · doi:10.3233/jpd-171176 · Cited by 88
Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in Neurodegeneration
Wales, P., Pinho, R., Lázaro, D. F., & Outeiro, T. F. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130216 · Cited by 86
Genes associated with Parkinson syndrome
Biskup, S., Gerlach, M., Kupsch, A. R., Reichmann, H., Riederer, P. F., Vieregge, P., Wüllner, U., & Gasser, T. (2008) · Journal of Neurology · doi:10.1007/s00415-008-5005-2 · Cited by 105
Bogaerts, V., Theuns, J., & Van Broeckhoven, C. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00342.x · Cited by 86
Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery
Arotçarena, M.-L., Teil, M., & Dehay, B. (2019) · Cells · doi:10.3390/cells8060565 · Cited by 97
Wang, C., Yang, T., Liang, M., Xie, J., & Song, N. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00265-y · Cited by 91
Matsuda, N., & Tanaka, K. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1231 · Cited by 88
Lysosomes and α-synuclein form a dangerous duet leading to neuronal cell death
Bourdenx, M., Bezard, E., & Dehay, B. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00083 · Cited by 81
How Parkinson's disease meets nucleolar stress
Parlato, R., & Liss, B. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.12.014 · Cited by 96
Self-citationDavison, E. J., Pennington, K., Hung, C., Peng, J., Rafiq, R., Ostareck‐Lederer, A., Ostareck, D. H., Ardley, H. C., Banks, R. E., & Robinson, P. A. (2009) · PROTEOMICS · doi:10.1002/pmic.200900126 · Cited by 88
Regulation of parkin and PINK1 by neddylation
Choo, Y. S., Vogler, G., Wang, D., Kalvakuri, S., Iliuk, A. B., Tao, W. A., Bodmer, R., & Zhang, Z. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds070 · Cited by 95
Genetics of Parkinson's Disease
Koros, C., Simitsi, A., & Stefanis, L. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.01.009 · Cited by 97
Structural effects of Parkinson's disease linked DJ‐1 mutations
Malgieri, G., & Eliezer, D. (2008) · Protein Science · doi:10.1110/ps.073411608 · Cited by 96
Kumaran, R., & Cookson, M. R. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv236 · Cited by 86
“Additionally, ATP13A2 expression was observed to be elevated in surviving dopaminergic neurons in human PD brains (122,126).”
BackgroundFunctionalization of the TMEM175 p.M393T variant as a risk factor for Parkinson disease
Jinn, S., Blauwendraat, C., Toolan, D., Gretzula, C. A., Drolet, R. E., Smith, S., Nalls, M. A., Marcus, J., Singleton, A. B., & Stone, D. J. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz136 · Cited by 80
A Practical Approach to Early-Onset Parkinsonism
Riboldi, G. M., Frattini, E., Monfrini, E., Frucht, S. J., & Fonzo, A. D. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212815 · Cited by 92
Progress in the pathogenesis and genetics of Parkinson's disease
Mizuno, Y., Hattori, N., Kubo, S., Sato, S., Nishioka, K., Hatano, T., Tomiyama, H., Funayama, M., Machida, Y., & Mochizuki, H. (2008) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2008.2273 · Cited by 107
ATP13A3 is a major component of the enigmatic mammalian polyamine transport system
Hamouda, N. N., Van den Haute, C., Vanhoutte, R., Sannerud, R., Azfar, M., Mayer, R., Cortés Calabuig, Á., Swinnen, J. V., Agostinis, P., Baekelandt, V., et al. (2021) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013908 · Cited by 85
Bian, M., Liu, J., Hong, X., Yu, M., Huang, Y., Sheng, Z., Fei, J., & Huang, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039953 · Cited by 80
Molecular pathogenesis of Parkinson's disease: update
Saiki, S., Sato, S., & Hattori, N. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301205 · Cited by 105
Qiao, C., Yin, N., Gu, H., Zhu, J., Ding, J., Lu, M., & Hu, G. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12514 · Cited by 76
Autophagy, lithium, and amyotrophic lateral sclerosis
Pasquali, L., Longone, P., Isidoro, C., Ruggieri, S., Paparelli, A., & Fornai, F. (2009) · Muscle & Nerve · doi:10.1002/mus.21423 · Cited by 83
Parkinson’s disease mouse models in translational research
Antony, P. M. A., Diederich, N. J., & Balling, R. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9330-x · Cited by 91
Taghavi, S., Chaouni, R., Tafakhori, A., Azcona, L. J., Firouzabadi, S. G., Omrani, M. D., Jamshidi, J., Emamalizadeh, B., Shahidi, G. A., Ahmadi, M., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0535-1 · Cited by 87
Ma, L., Zhao, Y., Chen, Y., Cheng, B., Peng, A., & Huang, K. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.11.051 · Cited by 91
Pathogenesis of Parkinson's disease: emerging role of molecular chaperones
Bandopadhyay, R., & de Belleroche, J. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.11.004 · Cited by 92
Harrington, A. J., Yacoubian, T. A., Slone, S. R., Caldwell, K. A., & Caldwell, G. A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2606-11.2012 · Cited by 82
Molecular Events Underlying Parkinson’s Disease – An Interwoven Tapestry
Lim, K., & Zhang, C. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00033 · Cited by 95
Genetic Profile, Environmental Exposure, and Their Interaction in Parkinson’s Disease
Polito, L., Greco, A., & Seripa, D. (2016) · Parkinson s Disease · doi:10.1155/2016/6465793 · Cited by 96
Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family
Wider, C. W., Skipper, L. M., Solida, A., Brown, L., Farrer, M. J., Dickson, D. W., Wszołek, Z. K., & Vingerhoets, F. J. G. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.11.013 · Cited by 85
Recent advances in Parkinson’s disease genetics
Lubbe, S. J., & Morris, H. R. (2013) · Journal of Neurology · doi:10.1007/s00415-013-7003-2 · Cited by 86
Higashi, S., Moore, D. J., Yamamoto, R., Minegishi, M., Sato, K., Togo, T., Katsuse, O., Uchikado, H., Furukawa, Y., Hino, H., et al. (2009) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e3181b44ed8 · Cited by 80
Cell Death Pathways in Parkinson's Disease: Role of Mitochondria
Yao, Z., & Wood, N. W. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2624 · Cited by 80
Bae, E.-J., Yang, N. Y., Lee, C., Kim, S., Lee, H.-J., & Lee, S.-J. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.283 · Cited by 76
Impairment of Lysosome Function and Autophagy in Rare Neurodegenerative Diseases
Darios, F. D., & Stévanin, G. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.02.033 · Cited by 91
Advances in protein-protein interaction network analysis for Parkinson's disease
Tomkins, J. E., & Manzoni, C. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105395 · Cited by 84
Parkinson's disease: Insights from non-traditional model organisms
Pienaar, I. S., Götz, J., & Feany, M. Β. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.09.001 · Cited by 85
Ruan, Q., Harrington, A. J., Caldwell, K. A., Caldwell, G. A., & Standaert, D. G. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.10.011 · Cited by 77
Photoconversion of Lysotracker Red to a green fluorescent molecule
Freundt, E. C., Czapiga, M., & Lenardo, M. J. (2007) · Cell Research · doi:10.1038/cr.2007.80 · Cited by 79
TBC1D20 mediates autophagy as a key regulator of autophagosome maturation
Sidjanin, D. J., Park, A. K., Ronchetti, A., Martins, J., & Jackson, W. T. (2016) · Autophagy · doi:10.1080/15548627.2016.1199300 · Cited by 81
The relationship of alpha-synuclein to mitochondrial dynamics and quality control
Thorne, N. J., & Tumbarello, D. A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.947191 · Cited by 82
Tardiff, D. F., Tucci, M. L., Caldwell, K. A., Caldwell, G. A., & Lindquist, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.308668 · Cited by 79
Wu, G., Wang, X., Feng, X., Zhang, A., Li, J., Gu, K., Huang, J. A., Pang, S., Dong, H., Gao, H., et al. (2011) · Brain Research · doi:10.1016/j.brainres.2011.04.013 · Cited by 83
Ansari, M. Y., Ball, H. C., Wase, S., Novak, K. A., & Haqqi, T. M. (2020) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2020.08.014 · Cited by 79
Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function
Kim, M. J., Jeon, S., Burbulla, L. F., & Krainc, D. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy105 · Cited by 81
Parkinson's disease: acid‐glucocerebrosidase activity and alpha‐synuclein clearance
Blanz, J., & Saftig, P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13517 · Cited by 71
The Emerging Functions of LRRK2 and Rab GTPases in the Endolysosomal System
Kuwahara, T., & Iwatsubo, T. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00227 · Cited by 68
Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease
Nuytemans, K., Bademci, G., Inchausti, V., Dressen, A., Kinnamon, D. D., Mehta, A., Wang, L., Züchner, S., Beecham, G. W., Martin, E. R., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31828727d4 · Cited by 72
Molecular basis of Parkinson's disease
Yang, Y. X., Wood, N. W., & Latchman, D. S. (2009) · Neuroreport · doi:10.1097/wnr.0b013e32831c50df · Cited by 76
Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease
Pitcairn, C., Wani, W. Y., & Mazzulli, J. R. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.03.008 · Cited by 75
ATP13A2 (PARK9) protein levels are reduced in brain tissue of cases with Lewy bodies
Murphy, K. E., Cottle, L., Gysbers, A. M., Cooper, A. A., & Halliday, G. M. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-11 · Cited by 74
Chen, W., Li, H., Liu, Z., & Yuan, W. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00068 · Cited by 80
Zhang, J., Culp, M. L., Craver, J. G., & Darley‐Usmar, V. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14308 · Cited by 73
Complicated recessive dystonia parkinsonism syndromes
Schneider, S. A., Bhatia, K. P., & Hardy, J. (2009) · Movement Disorders · doi:10.1002/mds.22314 · Cited by 76
Neurotoxin Mechanisms and Processes Relevant to Parkinson’s Disease: An Update
Segura‐Aguilar, J., & Kostrzewa, R. M. (2015) · Neurotoxicity Research · doi:10.1007/s12640-015-9519-y · Cited by 81
Identification of novel ATP13A2 interactors and their role in α-synuclein misfolding and toxicity
Usenovic, M., Knight, A. L., Ray, A., Wong, V., Brown, K. R., Caldwell, G. A., Caldwell, K. A., Stagljar, I., & Krainc, D. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds206 · Cited by 71
The multi‐faceted role of mitochondria in the pathology of Parkinson’s disease
Trinh, D., Israwi, A. R., Arathoon, L. R., Gleave, J. A., & Nash, J. E. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15154 · Cited by 77
Guadagnolo, D., Piane, M., Torrisi, M. R., Pizzuti, A., & Petrucci, S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.648588 · Cited by 79
ATP13A2 variants in early‐onset Parkinson's disease patients and controls
Djarmati, A., Hagenah, J., Reetz, K., Winkler, S., Behrens, M. I., Pawlack, H., Lohmann, K., Ramirez, A., Tadić, V., Brüggemann, N., et al. (2009) · Movement Disorders · doi:10.1002/mds.22728 · Cited by 72
Self-citationGenetically engineered mouse models of Parkinson's disease
Crabtree, D. M., & Zhang, J. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.07.019 · Cited by 70
Smolders, S., & Broeckhoven, C. V. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00935-4 · Cited by 75
Wöhlke, A., Philipp, U., Bock, P., Beineke, A., Lichtner, P., Meitinger, T., & Distl, O. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002304 · Cited by 73
Klein, C., Schneider, S. A., & Lang, A. E. (2009) · Movement Disorders · doi:10.1002/mds.22675 · Cited by 72
Matsui, H., Sato, F., Sato, S., Koike, M., Taruno, Y., Saiki, S., Funayama, M., Ito, H., Taniguchi, Y., Uemura, N., et al. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.02.046 · Cited by 71
Cotman, S. L., Karaa, A., Staropoli, J. F., & Sims, K. B. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0366-z · Cited by 70
Scott, L., Dawson, V. L., & Dawson, T. M. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.04.008 · Cited by 76
The Genetic Basis of Phenotypic Heterogeneity in the Neuronal Ceroid Lipofuscinoses
Gardner, E., & Mole, S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.754045 · Cited by 77
Biomarkers in Parkinson’s disease: A state of the art review
Yamashita, K. Y., Bhoopatiraju, S., Silverglate, B., & Grossberg, G. T. (2023) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2023.100074 · Cited by 83
Ubiquitin–proteasome system dysfunction in Parkinson’s disease: current evidence and controversies
Lim, K.-L. (2007) · Expert Review of Proteomics · doi:10.1586/14789450.4.6.769 · Cited by 71
Crosiers, D., Theuns, J., Cras, P. P., & Broeckhoven, C. V. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.07.003 · Cited by 87
Brahmachari, S., Lee, S., Kim, S., Yuan, C., Karuppagounder, S. S., Ge, P., Shi, R., Kim, E. J., Liu, A., Kim, D., et al. (2019) · Brain · doi:10.1093/brain/awz172 · Cited by 73
Xing, R., Zhou, H., Jian, Y., Li, L., Wang, M., Liu, N., Yin, Q., Liang, Z., Guo, W., & Yang, C. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202007061 · Cited by 73
Molecular Mechanisms of Pathogenesis of Parkinson's Disease
Shadrina, M. I., Slominsky, P. A., & Sa, L. (2010) · International review of cytology · doi:10.1016/s1937-6448(10)81006-8 · Cited by 85
Ragland, M. F., Hutter, C., Zabetian, C. P., & Edwards, K. L. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp288 · Cited by 75
Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinsons Disease
Rivero-Ríos, P., Madero-Pérez, Fernández, B., & Hilfiker, S. (2016) · Current Neuropharmacology · doi:10.2174/1570159x13666151030103027 · Cited by 69
Podhajska, A., Musso, A., Trancikova, A., Stafa, K., Moser, R., Sonnay, S., Glauser, L., & Moore, D. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039942 · Cited by 67
Effects of UCH‐L1 on α‐synuclein over‐expression mouse model of Parkinson’s disease
Yasuda, T., Nihira, T., Ren, Y., Cao, X., Wada, K., Setsuie, R., Kabuta, T., Wada, K., Hattori, N., Mizuno, Y., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05827.x · Cited by 66
Luna, E., & Luk, K. C. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.10.023 · Cited by 67
α-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities
Lööv, C., Scherzer, C. R., Hyman, B. T., Breakefield, X. O., & Ingelsson, M. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0317-0 · Cited by 75
Synergistic Effect of Mitochondrial and Lysosomal Dysfunction in Parkinson’s Disease
Guerra, F., Girolimetti, G., Beli, R., Mitruccio, M., Pacelli, C., Ferretta, A., Gasparre, G., Cocco, T., & Bucci, C. (2019) · Cells · doi:10.3390/cells8050452 · Cited by 70
Mutated ATP10B increases Parkinson’s disease risk by compromising lysosomal glucosylceramide export
Martin, S., Smolders, S., den Haute, C. V., Heeman, B., van Veen, S., Crosiers, D., Beletchi, I., Verstraeten, A., Gossye, H., Gelders, G., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02145-7 · Cited by 70
Parkinsonism syndrome in heterozygotes for Niemann–Pick C1
Kluenemann, H., Nutt, J. G., Davis, M. Y., & Bird, T. D. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.08.033 · Cited by 67
Phylogenetic analysis of P5 P-type ATPases, a eukaryotic lineage of secretory pathway pumps
Møller, A. B., Asp, T., Holm, P. B., & Palmgren, M. B. (2007) · Molecular Phylogenetics and Evolution · doi:10.1016/j.ympev.2007.10.023 · Cited by 75
Ugolino, J., Fang, S., Kubisch, C., & Monteiro, M. J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr274 · Cited by 65
Self-citationXie, W., Wan, O. W., & Chung, K. K. K. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.014 · Cited by 76
Parkinson disease related ATP13A2 evolved early in animal evolution
Sørensen, D. M., Holemans, T., van Veen, S., Martin, S., Arslan, T., Haagendahl, I. W., Holen, H. W., Hamouda, N. N., Eggermont, J., Palmgren, M. B., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193228 · Cited by 67
Juvenile dystonia-parkinsonism and dementia caused by a novel ATP13A2 frameshift mutation
Crosiers, D., Ceulemans, B., Meeus, B., Nuytemans, K., Pals, P., Broeckhoven, C. V., Cras, P. P., & Theuns, J. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.10.011 · Cited by 66
The Bad, the Good, and the Ugly about Oxidative Stress
Jimenez-Del-Rio, M., & Velez-Pardo, C. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/163913 · Cited by 64
Guo, J., Xiao, B., Liao, B., Zhang, X., Nie, L.-L., Zhang, Y., Shen, L. H., Jiang, H. F., Xia, K., Pan, Q., et al. (2008) · Movement Disorders · doi:10.1002/mds.22156 · Cited by 66
Vulnerability of mesostriatal dopaminergic neurons in Parkinson’s disease
González-Hernández, T. (2010) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2010.00140 · Cited by 65
Mutations in theATP13A2Gene and Parkinsonism: A Preliminary Review
Yang, X., & Xu, Y. (2014) · BioMed Research International · doi:10.1155/2014/371256 · Cited by 68
Flippases: still more questions than answers
Poulsen, L. R., López‐Marqués, R. L., & Palmgren, M. B. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8341-6 · Cited by 65
Bae, N.-Y., Ahn, T.-W., Chung, S., Oh, M. S., Ko, H., Oh, H., Park, G., & Yang, H. O. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.12.016 · Cited by 69
Mitochondrial dysfunction and Parkinson’s disease genes: insights from Drosophila
Park, J., Kim, Y., & Chung, J. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.003178 · Cited by 63
Manzoni, C., & Lewis, P. A. (2013) · The FASEB Journal · doi:10.1096/fj.12-223842 · Cited by 63
The emerging role of Rab GTPases in the pathogenesis of Parkinson's disease
Gao, Y., Wilson, G. R. A., Stephenson, S. E. M., Bozaoglu, K., Farrer, M. J., & Lockhart, P. J. (2018) · Movement Disorders · doi:10.1002/mds.27270 · Cited by 70
DNAJC proteins and pathways to parkinsonism
Roosen, D. A., Blauwendraat, C., Cookson, M., & Lewis, P. A. (2019) · FEBS Journal · doi:10.1111/febs.14936 · Cited by 68
Combination therapies: The next logical Step for the treatment of synucleinopathies?
Valera, E., & Masliah, E. (2016) · Movement Disorders · doi:10.1002/mds.26428 · Cited by 62
Metadata
- Authors
- Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., Al-Din, A., Hillmer, A. M., Karsak, M., Liss, B., Woods, C. G., Behrens, M. I., & Kubisch, C.
- Affiliations
- University of Cologne (DE)
- Philipps University of Marburg (DE)
- University of Leeds (GB)
- Centro de Estudios Científicos (CL)
- University of Bonn (DE)
- King Hussein Medical Center (JO)
- Pinderfields Hospital (GB)
- University of Cambridge (GB)
- Corresponding author
- Kubisch, Christian
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-09-10
- Volume
- 38
- Issue
- 10
- Pages
- 1184-1191
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2139369185
- Cited by
- 1,208
- References
- 30
- Citations by year
- 2026: 42 · 2025: 44 · 2024: 39 · 2023: 49 · 2022: 45 · 2021: 70 · 2020: 73 · 2019: 69 · 2018: 54 · 2017: 64 · 2016: 76 · 2015: 59 · 2014: 57 · 2013: 71 · 2012: 64
- FWCI
- 38.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Universidad de Chile (submittedVersion)
- Funders
- Tinker Foundation
- Wellcome Trust
- Royal Society
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Rheinische Friedrich-Wilhelms-Universität Bonn
- National Institutes of Health
- Directorate for Biological Sciences
- National Institute of Child Health and Human Development
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- ATP13A2, P-type ATPase, Kufor-Rakeb syndrome, PARK9, autosomal recessive inheritance, loss-of-function mutations, neurodegeneration, endoplasmic reticulum retention, proteasomal degradation, protein misfolding
- MeSH terms
- Adenosine Triphosphatases, Dementia, Endoplasmic Reticulum, Female, Proton-Translocating ATPases, Humans, Lysosomes, Male, Mesencephalon, Mutation, Neurons, Parkinsonian Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.